Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (QoQ) (2009 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66% |
| Sep 30, 2025 | 15.54% |
| Jun 30, 2025 | 48.12% |
| Mar 31, 2025 | -42.68% |
| Dec 31, 2024 | 146.19% |
| Sep 30, 2024 | 141.92% |
| Jun 30, 2024 | -424.02% |
| Mar 31, 2024 | 17.49% |
| Dec 31, 2023 | -2.08% |
| Sep 30, 2023 | 3.92% |
| Dec 31, 2020 | -5.62% |
| Sep 30, 2020 | -6.28% |
| Jun 30, 2020 | 1.60% |
| Mar 31, 2020 | 31.65% |
| Dec 31, 2019 | 466.82% |
| Sep 30, 2019 | -62.47% |
| Jun 30, 2019 | -2.27% |
| Mar 31, 2019 | 173.23% |
| Dec 31, 2018 | -38.09% |
| Sep 30, 2018 | 15.58% |
| Jun 30, 2018 | 24.74% |
| Dec 31, 2012 | -8,596.80% |
| Sep 30, 2012 | 90.85% |
| Jun 30, 2012 | -111.50% |
| Mar 31, 2012 | 23.94% |
| Dec 31, 2011 | -41.05% |
| Mar 31, 2011 | 38.54% |
| Dec 31, 2010 | 57.08% |
| Sep 30, 2010 | -9.72% |
| Jun 30, 2010 | -13.61% |
| Mar 31, 2010 | -26.01% |
| Dec 31, 2009 | 58.19% |
| Sep 30, 2009 | -62.74% |
| Jun 30, 2009 | 1.37% |